Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

819 public trials 296 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Recruiting

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

NCT06682195

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Nanchang People's Hospital Nanchang, Jiangxi, China
  • Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University Hangzhou, China
  • The First Affiliated Hospital of Zhejiang University Hangzhou, China
  • Zhejiang Cancer Hospital Hangzhou, China
View all 13 locations
View Trial Details
Recruiting

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

NCT05490472

Conditions
ARID1A Gene Mutation, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • Henry Ford Health System Detroit, Michigan, United States
  • Washington University St Louis, Missouri, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
  • University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details
Recruiting

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

NCT06999187

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • Dren Investigational Site Denver, Colorado, United States
  • Dren Investigational Site Orlando, Florida, United States
  • Dren Investigational Site Sarasota, Florida, United States
  • Dren Investigational Site Huntersville, North Carolina, United States
View Trial Details
Recruiting

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

NCT06399757

Conditions
Adenocarcinoma, Adenocarcinoma, Mucinous, Adnexal Diseases, +46 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details

Related conditions